MUROMACHI CHEMICALS, First Half Ordinary Profit Revised Upward to an Unexpected 55% Increase

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Tue Dec 17, 2024 3:00 pm JST Revision

4885 MUROMACHI CHEMICALS INC. 【J-GAAP】

Guidance Update Report

MUROMACHI CHEMICALS INC. <4885> [TSE Std] announced a performance revision in the afternoon session on December 17th (15:00). The ordinary profit (non-consolidated) for the cumulative second quarter of the fiscal year ending May 2025 (June to November) has been revised upward 88.9%, from the previous forecast of 90 million yen to 170 million yen (compared to 110 million yen in the same period of the previous year), turning to a 54.5% increase in the ordinary profit outlook.

Furthermore, the full-year ordinary profit forecast remains unchanged from the estimate of 430 million yen(compared to 428 million yen in the previous period).

Kabutan News

Guidance Update

First Half Update

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jun - Nov, 2024 Prev	3,000	100	90	65	16.3	0	Jul 12, 2024	J-GAAP
Jun - Nov, 2024 New	3,000	150	170	120	30.0	0	Dec 17, 2024	J-GAAP
Revision Rate	0.0%	+50.0%	+88.9%	+84.6%	+84.6%

Current Period Guidance

H1 Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jun - Nov, 2023	2,912	115	110	93	23.6	0	Jan 12, 2024	J-GAAP
Jun - Nov, 2024 Guidance	3,000	150	170	120	30.0	0	Dec 17, 2024	J-GAAP
YoY	+3.0%	+30.4%	+54.5%	+29.0%	+27.0%

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
May, 2023	6,291	369	350	256	67.9	19	Jul 14, 2023	J-GAAP
May, 2024	6,369	421	428	330	83.4	22	Jul 12, 2024	J-GAAP
May, 2025 Guidance	6,700	450	430	300	75.0	25	Jul 12, 2024	J-GAAP
YoY	+5.2%	+6.9%	+0.5%	-9.1%	-10.1%